Compliance Rate

Compliance Rate 0.0%
Compliant submissions 0
Incompliant submissions 1
Total trials 1

My Organizations' Clinical Trials

Showing 1725 of 3033 entries
View as:

Clinical Information and Biospecimen Collection from Patients with Recurrent or Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03737695 Org: User:
Start: 09/16/19 End: 11/15/27 Due: 11/15/28

A Study to Compare CSF Flow Metrics Across Platforms

Phase: N/A Priority: Normal
NCT ID: NCT05221918 Org: User:
Start: 09/14/22 End: 02/20/23 Due: 02/20/24

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase: N/A Priority: Normal
NCT ID: NCT06704191 Org: User:
Start: 04/21/25 End: 06/06/26 Due: 06/06/27

Effect of Gum Arabic on Gastrointestinal Transit and Permeability

Phase: N/A Priority: Normal
NCT ID: NCT03742076 Org: User:
Start: 12/18/18 End: 03/01/21 Due: 03/01/22

Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02999685 Org: User:
Start: 09/30/16 End: 06/30/19 Due: 06/30/20

Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates

Phase: N/A Priority: Normal
NCT ID: NCT03535584 Org: User:
Start: 06/12/18 End: 03/26/25 Due: 03/26/26

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05388006 Org: User:
Start: 01/05/23 End: 01/15/27 Due: 01/15/28

Molecular Modulation of the Growth Plate

Phase: N/A Priority: Normal
NCT ID: NCT03501589 Org: User:
Start: 10/31/13 End: 10/31/25 Due: 10/31/26

Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT01703143 Org: User:
Start: 05/31/11 End: 01/31/15 Due: 01/31/16

NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05992883 Org: User:
Start: 07/28/23 End: 12/31/25 Due: 12/31/26

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01748747 Org: User:
Start: 10/31/12 End: 03/30/17 Due: 03/30/18

An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

Phase: N/A Priority: Normal
NCT ID: NCT06999798 Org: User:
Start: 07/02/25 End: 07/30/26 Due: 07/30/27

Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02633059 Org: User:
Start: 12/30/15 End: 11/01/22 Due: 11/01/23

Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App

Phase: N/A Priority: Normal
NCT ID: NCT05324566 Org: User:
Start: 05/05/21 End: 07/09/24 Due: 07/09/25

Quality of Life Assessed With the PAH SYMPACT Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT03905421 Org: User:
Start: 03/06/19 End: 06/30/25 Due: 06/30/26

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02856568 Org: User:
Start: 05/01/17 End: 10/31/21 Due: 10/31/22

Optimal Endoscopic Suturing Pattern for Esophageal Stent Fixation

Phase: N/A Priority: Normal
NCT ID: NCT04007692 Org: User:
Start: 08/15/19 End: 11/30/20 Due: 11/30/21

Obstructive Sleep Apnea Among Somali-Americans

Phase: N/A Priority: Normal
NCT ID: NCT04124848 Org: User:
Start: 10/25/19 End: 12/31/28 Due: 12/31/29

Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid

Phase: N/A Priority: Normal
NCT ID: NCT05501041 Org: User:
Start: 08/22/22 End: 08/31/28 Due: 08/31/29

Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery

Phase: N/A Priority: Normal
NCT ID: NCT04730609 Org: User:
Start: 09/21/21 End: 08/31/25 Due: 08/31/26

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

Phase: N/A Priority: Normal
NCT ID: NCT06192875 Org: User:
Start: 09/28/15 End: 12/31/35 Due: 12/31/36

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01670084 Org: User:
Start: 12/31/12 End: 09/30/17 Due: 09/30/18

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Phase: N/A Priority: Normal
NCT ID: NCT06568549 Org: User:
Start: 06/13/25 End: 03/31/31 Due: 03/31/32

Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)

Phase: N/A Priority: Normal
NCT ID: NCT06319222 Org: User:
Start: 03/12/24 End: 06/30/26 Due: 06/30/27

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

Phase: N/A Priority: Normal
NCT ID: NCT01723553 Org: User:
Start: 11/30/12 End: 03/31/15 Due: 03/31/16